Market Research Report - 242762
Global Renal Denervation Devices Market 2012-2016
|Published by||TechNavio (Infiniti Research Ltd.)|
|Published||Content info||50 Pages|
|Global Renal Denervation Devices Market 2012-2016|
|Published: October 11, 2013||Content info: 50 Pages||
This publication has been discontinued on November 12, 2015.
TechNavio's analysts forecast the Global Renal Denervation Devices market to grow at a CAGR of 41.74 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of hypertension. The Global Renal Denervation Devices market has also been witnessing the increasing demand for minimally invasive procedures. However, the presence of alternative treatment therapy could pose a challenge to the growth of this market.
TechNavio's report, the Global Renal Denervation Devices Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Renal Denervation Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Boston Scientific Corp., Covidien plc, Medtronic Inc. and St. Jude Medical Inc.
Other vendors mentioned in the report are CardioSonic Inc., Kona Medical Inc., Mercator Medsystems Inc., ReCor Medical Inc., Sound Interventions Inc., and Terumo Corp.
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.